Evolution of the Average Target: Alignment Healthcare, Inc.

Evolution of the Target Price: Alignment Healthcare, Inc.

Changes in Analyst Recommendations: Alignment Healthcare, Inc.

c23c695f9938fb.bfWFpII_moldfP58kdpDEjAmRWuKgxHIxpA81XWQEAg.Jc3V5dR7wN4vPqgIxIk6R2FoAwPv4SH-gtpf7T3TXGMlxu6S9Q6p-RElyg~a9bab3b7d705245ef0998ead37d4d625
01-14 UBS Adjusts Alignment Healthcare Price Target to $21 From $18, Maintains Neutral Rating MT
31/10/25 UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating MT
25/08/25 Alignment Healthcare's Strong Medicare Advantage Model Supports Better Results, Higher Savings, KeyBanc Says MT
25/08/25 KeyBanc Upgrades Alignment Healthcare to Overweight From Sector Weight, Price Target is $21 MT
30/07/25 Alignment Healthcare Q2 revenue beats estimates; co raises annual outlook RE
02/05/25 UBS Adjusts Alignment Healthcare Price Target to $17 From $16, Maintains Neutral Rating MT
28/02/25 UBS Adjusts Price Target on Alignment Healthcare to $16 From $12, Keeps Neutral Rating MT
03/12/24 Stephens Upgrades Alignment Healthcare to Overweight From Equalweight, Price Target is $17 MT
30/10/24 UBS Adjusts Price Target on Alignment Healthcare to $12 From $9, Maintains Neutral Rating MT
11/10/24 KeyBanc Initiates Alignment Healthcare at Sector Weight MT
02/08/24 UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating MT
30/05/24 BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75 MT
30/05/24 Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target MT
08/05/24 Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral MT
03/05/24 UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating MT
23/04/24 Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating MT
06/03/24 Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12 MT
28/02/24 UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating MT
24/01/24 Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target MT
09/01/24 Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating MT
21/12/23 UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating MT
02/11/23 BofA Securities Downgrades Alignment Healthcare to Neutral From Buy MT
16/10/23 Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9 MT
12/10/23 Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target MT
30/08/23 Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+25.52%
+28.22%
+15.19%
+15.42%
+39.19%
+13.65%
+32.44%
+47.33%
+60.07%
+40.14%
Average +31.72%
Weighted average by Cap. +24.11%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.05USD
Average target price
25.17USD
Spread / Average Target
+25.52%
High Price Target
30.00USD
Spread / Highest target
+49.63%
Low Price Target
18.00USD
Spread / Lowest Target
-10.22%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

UBS
KeyBanc Capital Markets
Stephens Inc.
BofA Securities
Baird
Piper Sandler
Stifel Nicolaus
Raymond James
Morgan Stanley
JPMorgan Chase
Goldman Sachs
Cowen
Barclays
SVB Leerink
William Blair & Co.
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
20.05USD
Average target price
25.17USD
Spread / Average Target
+25.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ALHC Stock
  4. Consensus Alignment Healthcare, Inc.